276 related articles for article (PubMed ID: 34427858)
1. Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice.
Tarantini S; Balasubramanian P; Delfavero J; Csipo T; Yabluchanskiy A; Kiss T; Nyúl-Tóth Á; Mukli P; Toth P; Ahire C; Ungvari A; Benyo Z; Csiszar A; Ungvari Z
Geroscience; 2021 Oct; 43(5):2427-2440. PubMed ID: 34427858
[TBL] [Abstract][Full Text] [Related]
2. Treatment with the poly(ADP-ribose) polymerase inhibitor PJ-34 improves cerebromicrovascular endothelial function, neurovascular coupling responses and cognitive performance in aged mice, supporting the NAD+ depletion hypothesis of neurovascular aging.
Tarantini S; Yabluchanskiy A; Csipo T; Fulop G; Kiss T; Balasubramanian P; DelFavero J; Ahire C; Ungvari A; Nyúl-Tóth Á; Farkas E; Benyo Z; Tóth A; Csiszar A; Ungvari Z
Geroscience; 2019 Oct; 41(5):533-542. PubMed ID: 31679124
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological or genetic depletion of senescent astrocytes prevents whole brain irradiation-induced impairment of neurovascular coupling responses protecting cognitive function in mice.
Yabluchanskiy A; Tarantini S; Balasubramanian P; Kiss T; Csipo T; Fülöp GA; Lipecz A; Ahire C; DelFavero J; Nyul-Toth A; Sonntag WE; Schwartzman ML; Campisi J; Csiszar A; Ungvari Z
Geroscience; 2020 Apr; 42(2):409-428. PubMed ID: 31960269
[TBL] [Abstract][Full Text] [Related]
4. Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain.
Ahire C; Nyul-Toth A; DelFavero J; Gulej R; Faakye JA; Tarantini S; Kiss T; Kuan-Celarier A; Balasubramanian P; Ungvari A; Tarantini A; Nagaraja R; Yan F; Tang Q; Mukli P; Csipo T; Yabluchanskiy A; Campisi J; Ungvari Z; Csiszar A
Aging Cell; 2023 Jul; 22(7):e13832. PubMed ID: 37243381
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice.
Tarantini S; Valcarcel-Ares MN; Toth P; Yabluchanskiy A; Tucsek Z; Kiss T; Hertelendy P; Kinter M; Ballabh P; Süle Z; Farkas E; Baur JA; Sinclair DA; Csiszar A; Ungvari Z
Redox Biol; 2019 Jun; 24():101192. PubMed ID: 31015147
[TBL] [Abstract][Full Text] [Related]
6. Fusogenic liposomes effectively deliver resveratrol to the cerebral microcirculation and improve endothelium-dependent neurovascular coupling responses in aged mice.
Wiedenhoeft T; Tarantini S; Nyúl-Tóth Á; Yabluchanskiy A; Csipo T; Balasubramanian P; Lipecz A; Kiss T; Csiszar A; Csiszar A; Ungvari Z
Geroscience; 2019 Dec; 41(6):711-725. PubMed ID: 31654270
[TBL] [Abstract][Full Text] [Related]
7. Endothelial deficiency of insulin-like growth factor-1 receptor (IGF1R) impairs neurovascular coupling responses in mice, mimicking aspects of the brain aging phenotype.
Tarantini S; Nyúl-Tóth Á; Yabluchanskiy A; Csipo T; Mukli P; Balasubramanian P; Ungvari A; Toth P; Benyo Z; Sonntag WE; Ungvari Z; Csiszar A
Geroscience; 2021 Oct; 43(5):2387-2394. PubMed ID: 34383203
[TBL] [Abstract][Full Text] [Related]
8. Preventing spontaneous cerebral microhemorrhages in aging mice: a novel approach targeting cellular senescence with ABT263/navitoclax.
Faakye J; Nyúl-Tóth Á; Muranyi M; Gulej R; Csik B; Shanmugarama S; Tarantini S; Negri S; Prodan C; Mukli P; Yabluchanskiy A; Conley S; Toth P; Csiszar A; Ungvari Z
Geroscience; 2024 Feb; 46(1):21-37. PubMed ID: 38044400
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of catalase targeted to mitochondria improves neurovascular coupling responses in aged mice.
Csiszar A; Yabluchanskiy A; Ungvari A; Ungvari Z; Tarantini S
Geroscience; 2019 Oct; 41(5):609-617. PubMed ID: 31643012
[TBL] [Abstract][Full Text] [Related]
10. Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity.
He Y; Zhang X; Chang J; Kim HN; Zhang P; Wang Y; Khan S; Liu X; Zhang X; Lv D; Song L; Li W; Thummuri D; Yuan Y; Wiegand JS; Ortiz YT; Budamagunta V; Elisseeff JH; Campisi J; Almeida M; Zheng G; Zhou D
Nat Commun; 2020 Apr; 11(1):1996. PubMed ID: 32332723
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.
Zhu Y; Tchkonia T; Fuhrmann-Stroissnigg H; Dai HM; Ling YY; Stout MB; Pirtskhalava T; Giorgadze N; Johnson KO; Giles CB; Wren JD; Niedernhofer LJ; Robbins PD; Kirkland JL
Aging Cell; 2016 Jun; 15(3):428-35. PubMed ID: 26711051
[TBL] [Abstract][Full Text] [Related]
12. Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice.
Tarantini S; Valcarcel-Ares NM; Yabluchanskiy A; Fulop GA; Hertelendy P; Gautam T; Farkas E; Perz A; Rabinovitch PS; Sonntag WE; Csiszar A; Ungvari Z
Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29405550
[TBL] [Abstract][Full Text] [Related]
13. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.
Chang J; Wang Y; Shao L; Laberge RM; Demaria M; Campisi J; Janakiraman K; Sharpless NE; Ding S; Feng W; Luo Y; Wang X; Aykin-Burns N; Krager K; Ponnappan U; Hauer-Jensen M; Meng A; Zhou D
Nat Med; 2016 Jan; 22(1):78-83. PubMed ID: 26657143
[TBL] [Abstract][Full Text] [Related]
14. Elimination of senescent cells by treatment with Navitoclax/ABT263 reverses whole brain irradiation-induced blood-brain barrier disruption in the mouse brain.
Gulej R; Nyúl-Tóth Á; Ahire C; DelFavero J; Balasubramanian P; Kiss T; Tarantini S; Benyo Z; Pacher P; Csik B; Yabluchanskiy A; Mukli P; Kuan-Celarier A; Krizbai IA; Campisi J; Sonntag WE; Csiszar A; Ungvari Z
Geroscience; 2023 Oct; 45(5):2983-3002. PubMed ID: 37642933
[TBL] [Abstract][Full Text] [Related]
15. Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury.
Lim S; Kim TJ; Kim YJ; Kim C; Ko SB; Kim BS
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769397
[TBL] [Abstract][Full Text] [Related]
16. New agents that target senescent cells: the flavone, fisetin, and the BCL-X
Zhu Y; Doornebal EJ; Pirtskhalava T; Giorgadze N; Wentworth M; Fuhrmann-Stroissnigg H; Niedernhofer LJ; Robbins PD; Tchkonia T; Kirkland JL
Aging (Albany NY); 2017 Mar; 9(3):955-963. PubMed ID: 28273655
[TBL] [Abstract][Full Text] [Related]
17. Navitoclax (ABT263) reduces inflammation and promotes chondrogenic phenotype by clearing senescent osteoarthritic chondrocytes in osteoarthritis.
Yang H; Chen C; Chen H; Duan X; Li J; Zhou Y; Zeng W; Yang L
Aging (Albany NY); 2020 Jul; 12(13):12750-12770. PubMed ID: 32611834
[TBL] [Abstract][Full Text] [Related]
18. Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems.
Shang E; Zhang Y; Shu C; Ishida CT; Bianchetti E; Westhoff MA; Karpel-Massler G; Siegelin MD
Sci Rep; 2018 Oct; 8(1):15383. PubMed ID: 30337641
[TBL] [Abstract][Full Text] [Related]
19. TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo.
Karpel-Massler G; Bâ M; Shu C; Halatsch ME; Westhoff MA; Bruce JN; Canoll P; Siegelin MD
Oncotarget; 2015 Nov; 6(34):36456-71. PubMed ID: 26474387
[TBL] [Abstract][Full Text] [Related]
20. Microvascular dysfunction and neurovascular uncoupling are exacerbated in peripheral artery disease, increasing the risk of cognitive decline in older adults.
Owens CD; Mukli P; Csipo T; Lipecz A; Silva-Palacios F; Dasari TW; Tarantini S; Gardner AW; Montgomery PS; Waldstein SR; Kellawan JM; Nyul-Toth A; Balasubramanian P; Sotonyi P; Csiszar A; Ungvari Z; Yabluchanskiy A
Am J Physiol Heart Circ Physiol; 2022 Jun; 322(6):H924-H935. PubMed ID: 35333116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
